KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)

CUSIP: 48669G105

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / American Depositary Shares
Shares outstanding
11,337,576
Total 13F shares
249,972
Share change
-3,446
Total reported value
$670,139
Price per share
$4.34
Number of holders
7
Value change
-$8,525
Number of buys
3
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 48669G105?
CUSIP 48669G105 identifies KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) as of Q4 2019

As of 31 Dec 2019, KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 249,972 shares. The largest 7 holders included Transform Wealth, LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, HighPoint Advisor Group LLC, UBS Group AG, Steward Partners Investment Advisory, LLC, and BREWIN DOLPHIN LTD. This page lists 7 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.